Actively Recruiting

Phase 3
Age: 0Years - 6Years
All Genders
NCT02781922

Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)

Led by Metcela Inc. · Updated on 2025-09-30

40

Participants Needed

4

Research Sites

652 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the efficacy and safety of intracoronary injection of JRM-001 after reconstructive surgery in pediatric patients with functional single ventricle

CONDITIONS

Official Title

Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)

Who Can Participate

Age: 0Years - 6Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Functional single ventricle patient with heart failure who is scheduled for stage 2 (Glenn) or stage 3 (Fontan) surgery
  • Ejection fraction (EF%) by echocardiography 55% or less
  • Written informed consent obtained from a parent
Not Eligible

You will not qualify if you...

  • Known history of cardiogenic shock
  • Lethal, uncontrollable arrhythmia
  • Coronary artery disease
  • Eisenmenger syndrome
  • Brain dysfunction due to circulatory failure
  • Malignant neoplasm
  • Severe neurologic disorder
  • Severe pulmonary embolism or pulmonary hypertension
  • Severe renal failure
  • Multiple organ failure
  • Active infection including endocarditis
  • Sepsis
  • Active hemorrhagic disease such as gastrointestinal bleeding or injury
  • Known hypersensitivity to anti-infective drugs
  • Inability to complete treatment and follow-up examinations

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Kanagawa Children's Medical Center

Kanagawa, Japan

Actively Recruiting

2

Okayama University Hospital

Okayama, Japan

Actively Recruiting

3

Saitama Prefectural Children's Medical Center

Saitama, Japan

Actively Recruiting

4

Shizuoka Children's Hospital

Shizuoka, Japan

Actively Recruiting

Loading map...

Research Team

M

Metcela Inc. (former Japan Regenerative Medicine Co., Ltd.)

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here